Lab-made antibody 'neutralizes' COVID-19 virus, study shows

Researchers have created an antibody that may neutralize SARS-CoV-2, offering potential prevention and treatment for the disease COVID-19, according to a study published May 4 in the scientific journal Nature Communications.

The antibody, known as 47D11, was created in a lab and can neutralize the spike protein found in SARS-CoV-2, the virus that causes COVID-19. Researchers are still not certain how the antibody neutralizes the spike protein. 

The 47D11 antibody is known as a monoclonal antibody, or a lab-made antibody, which have increasingly been recognized as a promising drug form against infectious diseases, according to the report.

Though it is still early in the development of any potential drug, the antibody shows promise, the researchers concluded.


You can unsubscribe from these communications at any time. For more information, please review our Privacy Policy
.
 

Copyright © 2025 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Articles We Think You'll Like

 

Featured Whitepapers

Featured Webinars